...
首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Association between Ki-67 Labeling index and Histopathological Grading of Glioma in Indonesian Population
【24h】

Association between Ki-67 Labeling index and Histopathological Grading of Glioma in Indonesian Population

机译:印度尼西亚人口粘性胶质瘤的ki-67标记指数与组织病理学分级的关系

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Gliomas are the most frequent primary brain tumors. According to World Health Organization guidelines, gliomas are graded into four groups (Group I-IV). This histological grading will determine prognosis and treatment of the patient. Morphological criteria are not always accurate. Tumor proliferation index is a potent quantitative marker for tumor behavior and prognosis, also it’s the basis of gliomagenesis. Ki-67 immunohistochemistry examination for determining proliferation index has been suggested as an ancillary marker in deciding the definitive grading of glioma. Objective: To analyze the correlation between Ki-67 labeling index and histopathological grading of glioma in Indonesian population. Methods: One hundred and six formalin fixed-paraffin embedded tissue of glioma patients were collected from 4 different hospitals. Expression of Ki-67 was detected using immunohistochemistry staining and the labeling index was counted. The association between Ki-67 labeling index and histopathological grading was analyzed. Results: Age range of patient were 1-73-years old, with male predominance (55.70%). Glioblastoma was the most common diagnosis accounting for 41.51% of all samples. Ki-67 labeling index cut point of 6.35% was obtained and significantly sensitive and specific for determining low- or high-grade glioma (p0.001). Conclusion: A significant association between Ki-67 labeling index and histopathological grading in Indonesian glioma patients has been revealed. The result of this study may be used to improve diagnostic and grading accuracy of glioma cases in Indonesia, especially in small biopsy specimens.
机译:背景:胶质瘤是最常见的原发性脑肿瘤。根据世界卫生组织的指导方针,GLIOMAS分为四组(第IV组)。该组织学分级将确定患者的预后和治疗。形态学标准并不总是准确。肿瘤增殖指数是肿瘤行为和预后的有效的定量标志,也是胶质瘤的基础。在决定神经胶质瘤的明确分级时,已提出用于确定增殖指数的Ki-67免疫组化检查。目的:分析印度尼西亚人群胶质瘤ki-67标记指数与组织病理学分析的相关性。方法:从4个不同的医院收集胶质瘤患者的一百六个福尔马林固定石蜡嵌入式组织。使用免疫组织化学染色检测KI-67的表达,并且计算标记指数。分析了KI-67标记指数与组织病理学分级之间的关联。结果:患者年龄范围为1-73岁,男性优势(55.70%)。胶质母细胞瘤是最常见的诊断占所有样品的41.51%。 ki-67标记指数切割点为6.35%,得到明显敏感和特异性,用于确定低级或高级胶质瘤(p <0.001)。结论:揭示了印度尼西亚胶质瘤患者的KI-67标记指数与组织病理学分级的重大关联。该研究的结果可用于改善印度尼西亚胶质瘤病例的诊断和分级准确性,特别是在小型活组织检查标本中。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号